EP2345668
SCLEROSTIN EPITOPES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.4.2006EP published:
22.9.2021EP application number:
10014360.1
EPO information:
European Patent Register
Max expiry date:
27.4.2026
Title:
SCLEROSTIN EPITOPES
Timeline
Today
28.4.2006EP application
22.9.2021EP Publication
Owner
Name:
UCB Pharma, S.A.Address:
Allée de la Recherche 60, 1070 Bruxelles, BE
Name:
Amgen, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
Lu, Hsieng SenAddress:
Westlake Village California 91362, US
Name:
Paszty, ChristopherAddress:
Ventura California 93003, US
Name:
Robinson, Martyn KimAddress:
Woodburn Green Buckinghamshire HP10 0JH, GB
Name:
Henry, Alistair JamesAddress:
Uxbridge Middlesex UB 8 2LX, GB
Name:
Hoffmann, Kelly SueAddress:
Newbury Park California 91320, US
Name:
Latham, JohnAddress:
Seattle Washington 98119, US
Name:
Lawson, AlastairAddress:
Slough Berkshire SL1 3WE, GB
Name:
Winkler, DavidAddress:
Arlington Massachusetts 02476-7326, US
Name:
Winters, Aaron GeorgeAddress:
Ventura California 93001, US
Priority
Number:
677583 PDate:
3.5.2005Country:
US
Number:
776847 PDate:
24.2.2006Country:
US
Number:
782244 PDate:
13.3.2006Country:
US
Number:
792645 PDate:
17.4.2006Country:
US
Number:
410540Date:
25.4.2006Country:
US
Classification
Categories:
C07K 16/22, A61K 39/00, C12N 15/63, A61P 15/12, C07K 14/51, A61P 19/00, A61P 19/08, A61P 19/10, A61P 43/00